AIMS: To determine if awareness of, interest in, and use of direct-to-consumer (DTC) genetic testing is greater in a sample of high-risk individuals (cancer cases and their relatives), compared to controls. METHODS: Participants were recruited from the Northwest Cancer Genetics Network. A follow-up survey was mailed to participants to assess DTC genetic testing awareness, interest, and use. RESULTS: One thousand two hundred sixty-seven participants responded to the survey. Forty-nine percent of respondents were aware of DTC genetic testing. Of those aware, 19% indicated interest in obtaining and <1% reported having used DTC genetic testing. Additional information supplied by respondents who reported use of DTC genetic tests indicated that 55% of these respondents likely engaged in clinical genetic testing, rather than DTC genetic testing. CONCLUSION: Awareness of DTC genetic testing was greater in our sample of high-risk individuals than in controls and population-based studies. Although interest in and use of these tests among cases in our sample were equivalent to other population-based studies, interest in testing was higher among relatives and people who self-referred for a registry focused on cancer than among cases and controls. Additionally, our results suggest that there may be some confusion about what constitutes DTC genetic testing.
AIMS: To determine if awareness of, interest in, and use of direct-to-consumer (DTC) genetic testing is greater in a sample of high-risk individuals (cancer cases and their relatives), compared to controls. METHODS:Participants were recruited from the Northwest Cancer Genetics Network. A follow-up survey was mailed to participants to assess DTC genetic testing awareness, interest, and use. RESULTS: One thousand two hundred sixty-seven participants responded to the survey. Forty-nine percent of respondents were aware of DTC genetic testing. Of those aware, 19% indicated interest in obtaining and <1% reported having used DTC genetic testing. Additional information supplied by respondents who reported use of DTC genetic tests indicated that 55% of these respondents likely engaged in clinical genetic testing, rather than DTC genetic testing. CONCLUSION: Awareness of DTC genetic testing was greater in our sample of high-risk individuals than in controls and population-based studies. Although interest in and use of these tests among cases in our sample were equivalent to other population-based studies, interest in testing was higher among relatives and people who self-referred for a registry focused on cancer than among cases and controls. Additionally, our results suggest that there may be some confusion about what constitutes DTC genetic testing.
Authors: Katrina A B Goddard; Debra Duquette; Amy Zlot; Jenny Johnson; Ann Annis-Emeott; Patrick W Lee; Mary Pat Bland; Karen L Edwards; Kristin Oehlke; Rebecca T Giles; Ann Rafferty; Michelle L Cook; Muin J Khoury Journal: Am J Public Health Date: 2008-12-23 Impact factor: 9.308
Authors: Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Lawrence C Brody; Andreas D Baxevanis Journal: J Med Internet Res Date: 2010-09-29 Impact factor: 5.428
Authors: Hoda Anton-Culver; Argyrios Ziogas; Deborah Bowen; Dianne Finkelstein; Constance Griffin; James Hanson; Claudine Isaacs; Carol Kasten-Sportes; Geraldine Mineau; Prakash Nadkarni; Barbara Rimer; Joellen Schildkraut; Louise Strong; Barbara Weber; Deborah Winn; Robert Hiatt; Susan Nayfield Journal: Community Genet Date: 2003
Authors: Kelly F J Stewart; Daša Kokole; Anke Wesselius; Annemie M W J Schols; Maurice P Zeegers; Hein de Vries; Liesbeth A D M van Osch Journal: Public Health Genomics Date: 2018-10-25 Impact factor: 2.000